• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Revisiting the debate: the use of new agents in previously untreated patients with small cell lung cancer; quality versus duration of survival.

作者信息

Markman M

出版信息

J Cancer Res Clin Oncol. 1994;120(12):693-4. doi: 10.1007/BF01194264.

DOI:10.1007/BF01194264
PMID:7798291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12200610/
Abstract
摘要

相似文献

1
Revisiting the debate: the use of new agents in previously untreated patients with small cell lung cancer; quality versus duration of survival.重新审视这场辩论：在既往未接受治疗的小细胞肺癌患者中使用新型药物；生存质量与生存时长
J Cancer Res Clin Oncol. 1994;120(12):693-4. doi: 10.1007/BF01194264.
2
Chemotherapy versus best supportive care for extensive small cell lung cancer.广泛期小细胞肺癌的化疗与最佳支持治疗对比
Cochrane Database Syst Rev. 2013 Nov 27;2013(11):CD001990. doi: 10.1002/14651858.CD001990.pub3.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Long-term survival in small cell lung cancer patients is correlated with high interleukin-2 secretion at diagnosis.小细胞肺癌患者的长期生存与诊断时白细胞介素-2的高分泌相关。
J Cancer Res Clin Oncol. 2000 Dec;126(12):730-3. doi: 10.1007/pl00008479.
5
Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review.肠外抗凝治疗可能会延长局限期小细胞肺癌患者的生存期：一项Cochrane系统评价
J Exp Clin Cancer Res. 2008 May 15;27(1):4. doi: 10.1186/1756-9966-27-4.
6
Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis.粒细胞和粒细胞巨噬细胞集落刺激因子在小细胞肺癌治疗中的作用：一项具有方法学评估和荟萃分析的文献系统综述
Lung Cancer. 2002 Aug;37(2):115-23. doi: 10.1016/s0169-5002(02)00082-x.
7
Duration of chemotherapy in small cell lung cancer.小细胞肺癌的化疗疗程
Thorax. 1990 Jan;45(1):1-2. doi: 10.1136/thx.45.1.1.
8
Chemotherapy plus surgery versus surgery alone in non-small-cell lung cancer.非小细胞肺癌中化疗联合手术与单纯手术的对比
N Engl J Med. 1994 Jun 16;330(24):1756; author reply 1757. doi: 10.1056/NEJM199406163302413.
9
The debate about maintenance is not over in small-cell lung cancer.关于小细胞肺癌维持治疗的争论尚未结束。
J Clin Oncol. 2007 Dec 20;25(36):5840; author reply 5840-1. doi: 10.1200/JCO.2007.14.6183.
10
Early versus late chest radiotherapy for limited stage small cell lung cancer.局限期小细胞肺癌的早期与晚期胸部放疗
Cochrane Database Syst Rev. 2005 Jan 25;2004(1):CD004700. doi: 10.1002/14651858.CD004700.pub2.

本文引用的文献

1
Phase II trial of edatrexate in small cell lung cancer.依达曲沙治疗小细胞肺癌的II期试验。
Cancer. 1994 Feb 15;73(4):1189-93. doi: 10.1002/1097-0142(19940215)73:4<1189::aid-cncr2820730411>3.0.co;2-g.
2
Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
J Clin Oncol. 1986 Apr;4(4):524-7. doi: 10.1200/JCO.1986.4.4.524.
3
Testing new drugs in untreated small cell lung cancer may prejudice the results of standard treatment: a phase II study of oral idarubicin in extensive disease.在未经治疗的小细胞肺癌中测试新药可能会影响标准治疗的结果：一项关于口服伊达比星治疗广泛期疾病的II期研究。
Cancer Treat Rep. 1987 Dec;71(12):1227-30.
4
Identification of new drugs in small cell lung cancer: phase II agents first?
Cancer Treat Rep. 1987 Dec;71(12):1131-3.
5
Phase II study of 1,2,4-triglycidylurazol (TGU) in previously untreated and treated patients with small cell lung cancer.1,2,4-三缩水甘油基脲唑（TGU）用于既往未接受治疗及已接受治疗的小细胞肺癌患者的II期研究。
Eur J Cancer Clin Oncol. 1987 Jul;23(7):1031-3. doi: 10.1016/0277-5379(87)90354-3.
6
Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.氨萘非特的II期研究：在既往未经治疗的广泛期小细胞肺癌患者中使用一种研究性药物的治疗结果及经验教训
J Clin Oncol. 1990 Mar;8(3):390-5. doi: 10.1200/JCO.1990.8.3.390.
7
Epirubicin in extensive small-cell lung cancer: a phase II study in previously untreated patients: a National Cancer Institute of Canada Clinical Trials Group Study.表柔比星治疗广泛期小细胞肺癌：一项针对既往未接受治疗患者的II期研究：加拿大国家癌症研究所临床试验组研究
J Clin Oncol. 1990 Mar;8(3):385-9. doi: 10.1200/JCO.1990.8.3.385.
8
Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.在选定的未经治疗的广泛期小细胞肺癌患者中评估新型抗癌药物的理由：一项东部肿瘤协作组的随机研究
J Natl Cancer Inst. 1992 Jul 15;84(14):1077-84. doi: 10.1093/jnci/84.14.1077.
9
Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.
J Clin Oncol. 1992 Mar;10(3):484-98. doi: 10.1200/JCO.1992.10.3.484.